ArticleOncoTargets and therapy2013

Human telomerase reverse-transcriptase promoter-controlled and herpes simplex virus thymidine kinase-armed adenoviruses for renal cell carcinoma treatment.

Dawei Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.